MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-03-0020741
Ariseetios Pharmaceutical Private Limited
Ariseetios Pharmaceutical Private Limited - pharma in Ranchi, Jharkhand, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹32.86 Lakh
▼ 31% YoY
Net profit · FY 2025
₹28,050
Net margin 0.9%
EBITDA · FY 2025
₹87,523
EBITDA margin 2.7%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹10 Lakh
Secured borrowings
Company age
13 yrs
Est. 2013
Directors on board
2
As per MCA filings
About Ariseetios Pharmaceutical Private Limited
Data last updated:
Ariseetios Pharmaceutical Private Limited is a private limited company based in Ranchi, Jharkhand, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 14 August 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Ranchi, under CIN U85100JH2013PTC001529. Its GSTIN is 20AALCA8964B1ZU (Jharkhand).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Aditya Upadhyay and Shobha Upadhyay.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Dulari Bhawan 1st Floor Lake Road Behind Agrasen Bhawan West Radha Marge, Ranchi, Jharkhand, India – 834001.
As per the financials filed for FY 2025, the company reported a revenue of ₹32.86 Lakh, a decline of 31% compared to the previous year. For the same year it recorded a net profit of ₹28,050 (net margin 0.9%) and EBITDA of ₹87,523 (EBITDA margin 2.7%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 2% over five years.
As per MCA filings, the company has open charges of ₹10 Lakh on record.
Ariseetios Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-03-0020741). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U85100JH2013PTC001529
Registration Number 001529
Incorporation Date 14 August 2013
ROC Ranchi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-03-0020741
Key People
Aditya Upadhyay Director Shobha Upadhyay Director Recognitions & Rankings of Ariseetios Pharmaceutical
Contact details
Ariseetios Pharmaceutical Private Limited's registered office is in Ranchi, Jharkhand. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressDulari Bhawan 1st Floor Lake Road Behind Agrasen Bhawan West Radha Marge, Ranchi, Jharkhand, India – 834001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Ariseetios Pharmaceutical Private Limited, buy the company report.
Comprehensive company report
Ariseetios Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Ariseetios Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Ariseetios Pharmaceutical Private Limited, buy the company report.
Financials of Ariseetios Pharmaceutical Private Limited
FY 2025 filings availableAriseetios Pharmaceutical Private Limited reported revenue of ₹32.86 Lakh (down 31% YoY) for FY 2025.
Revenue · FY 2025
₹32.86 Lakh ▼ 31%
Net profit · FY 2025
₹28,050 margin 0.9%
EBITDA · FY 2025
₹87,523 margin 2.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 31%
3 years · compounded
▼ 1%
5 years · compounded
▲ 2%
EBITDA CAGR growth
1 year
▼ 6%
3 years · compounded
▲ 25%
5 years · compounded
▲ 17%
Revenue fell 31% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 2%. EBITDA fell 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹87,523 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹28,050 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.7% | ||||
| Net Profit Margin | 0.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ariseetios Pharmaceutical Private Limited, buy the company report.
Board of directors of Ariseetios Pharmaceutical Private Limited
Ariseetios Pharmaceutical has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aditya Upadhyay Also directs: Aarogya Digital Health Solutions Private Limited | Director | 15 Nov 2023 | 2 Years 11 Months | Current |
| Shobha Upadhyay | Director | 14 Aug 2013 | 13 Years 2 Months | Current |
Peer comparison
Ariseetios Pharmaceutical Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Charitra Pharmaceuticals Private Limited | ₹33.08 Lakh (FY 2023) | 25.0% | Hyderabad, Telangana, India | |||
| Ariseetios Pharmaceutical Private Limitedthis company | ₹32.86 Lakh (FY 2025) | ₹28,050 | 0.9% | -31.0% | Ranchi, Jharkhand, India | |
| Noble Remedies(India)Pvt Ltd | ₹32.8 Lakh (FY 2024) | -1.0% | Haryana, India | |||
| Etico Research Private Limited | ₹32.77 Lakh (FY 2024) | Hyderabad, Telangana, India | ||||
| Heilent Pharmaceuticals Private Limited | ₹32.7 Lakh (FY 2025) | -16.0% | Sulthan Bathery, Kerala, India |
To see the full peer comparison of Ariseetios Pharmaceutical Private Limited, buy the company report.
Auditor
Ariseetios Pharmaceutical Private Limited is audited by KUMAR ANAND & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KUMAR ANAND & ASSOCIATES | FY 2017 | 018092C |
Shareholding
The shareholding of Ariseetios Pharmaceutical Private Limited is on record for 4 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Ariseetios Pharmaceutical Private Limited, buy the company report.
Charges & borrowings
Open charges
₹10 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 16 Feb 2023 | 100720006 | Others | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Ariseetios Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ariseetios Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ariseetios Pharmaceutical has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 20AALCA8964B1ZU | Jharkhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Ariseetios Pharmaceutical Private Limited, buy the company report.
Recent activity
Ariseetios Pharmaceutical Private Limited has 3 board changes on record since 2013: 2 appointments and 1 cessation. The latest: Manoj Kumar Upadhyay ceased to be Director on 21 Nov 2023.
AGM
Ariseetios Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Ariseetios Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ranchi.
Ceased
Manoj Kumar Upadhyay ceased to be Director.
Appointed
Aditya Upadhyay was appointed as Director.
Charges
A charge with Others amounted to Rs. 10.00 Lakh with Charge ID 100720006 was registered on 16 Feb 2023.
Appointed
Shobha Upadhyay was appointed as Director.
Incorporation
14 Aug 2013
Ariseetios Pharmaceutical Private Limited was registered on 14 Aug 2013 with Roc Ranchi & aged 13 years 2 months as per MCA records.
Frequently asked questions
Ariseetios Pharmaceutical is an active private limited company based in Ranchi, Jharkhand, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 14 August 2013 (13+ years old) and is registered under CIN U85100JH2013PTC001529.
Ariseetios Pharmaceutical has 2 current directors:
- Aditya Upadhyay - Director
- Shobha Upadhyay - Director
The latest financial statements of Ariseetios Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Ariseetios Pharmaceutical is 20AALCA8964B1ZU, registered in Jharkhand.
The CIN (Corporate Identification Number) of Ariseetios Pharmaceutical is U85100JH2013PTC001529. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ariseetios Pharmaceutical was incorporated on 14 August 2013, making it 13+ years old. It is registered with the Registrar of Companies, Ranchi.
The peers of Ariseetios Pharmaceutical by revenue are Charitra Pharmaceuticals Private Limited, Noble Remedies(India)Pvt Ltd, Etico Research Private Limited, Heilent Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Manoj Kumar Upadhyay ceased to be Director on 21 Nov 2023. Aditya Upadhyay was appointed as Director on 15 Nov 2023. Shobha Upadhyay was appointed as Director on 14 Aug 2013.
Yes, Ariseetios Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-03-0020741).
The registered office of Ariseetios Pharmaceutical is at Dulari Bhawan 1st Floor Lake Road Behind Agrasen Bhawan West Radha Marge, Ranchi, Jharkhand, India – 834001.
Ariseetios Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.